FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055148524> ?p ?o ?g. }

• W2055148524 endingPage "2999" @default.
• W2055148524 startingPage "2990" @default.
• W2055148524 abstract "Background. Clinical drug resistance is recognized in patients previously treated with radiotherapy and after chemotherapy. In vitro exposure of mammalian tumor cells to fractionated X-irradiation also resulted in the expression of drug resistance. Analysis of the resistance phenotype of irradiated Chinese hamster ovary sublines revealed P-glycoprotein overexpression, without any concomitant increase in P-glycoprotein messenger RNA, under posttranslational regulation. This study aimed to determine whether this distinctive resistance phenotype could also be identified in irradiated human tumor cells. Methods. Irradiated sublines established from two human ovarian tumor cell lines, SK-OV-3 and JA-T, which showed resistance to vincristine and to etoposide, were studied. Protein and RNA expression were quantitated by Western and Northern blotting or RNase protection assays. P-glycoprotein turnover was measured after immunoprecipitation of metabolically labelled cells. Results. Significant P-glycoprotein overexpression was detected using the C219 and C494 monoclonal antibodies in the two irradiated human ovarian tumor sublines. No concomitant increase in P-glycoprotein messenger RNA was detectable in the SK-OV-3/DXR10 subline, contrasting with the increased message characteristic of vincristine-selected SKVCR sublines. In addition, turnover of P-glycoprotein was significantly reduced in these DXR10 cells when compared with that measured in a vincristine-selected subline. These irradiated sublines showed reduced levels of epidermal growth factor receptors and unchanged levels of topoisomerase II, but they overexpressed c-erbB2 marginally and heat shock protein 27 significantly. These latter elevations in protein levels, however, were associated with concomitant increases in their respective messenger RNAs, implicating regulation at the transcriptional level. Conclusions. Exposure of human ovarian tumor cells to fractionated X-irradiation in vitro resulted in the expression of a distinctive multiple drug resistance phenotype unusually involving posttranslational regulation of P-glycoprotein. Monitoring tumor biopsies for P-glycoprotein-associated drug resistance in patients treated with radiotherapy should evaluate protein levels rather than, or as well as, MDR1 mRNA expression. Cancer 1994; 73:2990–9." @default.
• W2055148524 created "2016-06-24" @default.
• W2055148524 creator A5059041659 @default.
• W2055148524 creator A5060819762 @default.
• W2055148524 creator A5061922767 @default.
• W2055148524 creator A5083725445 @default.
• W2055148524 date "1994-06-15" @default.
• W2055148524 modified "2023-10-03" @default.
• W2055148524 title "Identification of a distinctive p-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated x-irradiation" @default.
• W2055148524 cites W1482317169 @default.
• W2055148524 cites W1592664042 @default.
• W2055148524 cites W1608668783 @default.
• W2055148524 cites W1685536199 @default.
• W2055148524 cites W1775749144 @default.
• W2055148524 cites W1866683333 @default.
• W2055148524 cites W1968082579 @default.
• W2055148524 cites W1971950332 @default.
• W2055148524 cites W1977778510 @default.
• W2055148524 cites W1984516227 @default.
• W2055148524 cites W1985089147 @default.
• W2055148524 cites W2006558753 @default.
• W2055148524 cites W2007931369 @default.
• W2055148524 cites W2010004581 @default.
• W2055148524 cites W2017709084 @default.
• W2055148524 cites W2026072303 @default.
• W2055148524 cites W2026558641 @default.
• W2055148524 cites W2027983777 @default.
• W2055148524 cites W2034687052 @default.
• W2055148524 cites W2045220494 @default.
• W2055148524 cites W2049772927 @default.
• W2055148524 cites W2050976525 @default.
• W2055148524 cites W2054375978 @default.
• W2055148524 cites W2060333964 @default.
• W2055148524 cites W2066943324 @default.
• W2055148524 cites W2068844189 @default.
• W2055148524 cites W2069019428 @default.
• W2055148524 cites W2075064101 @default.
• W2055148524 cites W2076813962 @default.
• W2055148524 cites W2095156669 @default.
• W2055148524 cites W2098627801 @default.
• W2055148524 cites W2113214957 @default.
• W2055148524 cites W2131823259 @default.
• W2055148524 cites W2142462050 @default.
• W2055148524 cites W2153712534 @default.
• W2055148524 cites W2156748982 @default.
• W2055148524 cites W2209643404 @default.
• W2055148524 cites W2255703111 @default.
• W2055148524 cites W2264155967 @default.
• W2055148524 cites W2410473994 @default.
• W2055148524 cites W29163176 @default.
• W2055148524 cites W4241531133 @default.
• W2055148524 cites W4293247451 @default.
• W2055148524 cites W62063735 @default.
• W2055148524 doi "https://doi.org/10.1002/1097-0142(19940615)73:12<2990::aid-cncr2820731217>3.0.co;2-l" @default.
• W2055148524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7911070" @default.
• W2055148524 hasPublicationYear "1994" @default.
• W2055148524 type Work @default.
• W2055148524 sameAs 2055148524 @default.
• W2055148524 citedByCount "20" @default.
• W2055148524 countsByYear W20551485242012 @default.
• W2055148524 countsByYear W20551485242015 @default.
• W2055148524 countsByYear W20551485242017 @default.
• W2055148524 countsByYear W20551485242018 @default.
• W2055148524 crossrefType "journal-article" @default.
• W2055148524 hasAuthorship W2055148524A5059041659 @default.
• W2055148524 hasAuthorship W2055148524A5060819762 @default.
• W2055148524 hasAuthorship W2055148524A5061922767 @default.
• W2055148524 hasAuthorship W2055148524A5083725445 @default.
• W2055148524 hasBestOaLocation W20551485241 @default.
• W2055148524 hasConcept C104317684 @default.
• W2055148524 hasConcept C105580179 @default.
• W2055148524 hasConcept C114851261 @default.
• W2055148524 hasConcept C133936738 @default.
• W2055148524 hasConcept C153911025 @default.
• W2055148524 hasConcept C159654299 @default.
• W2055148524 hasConcept C175656101 @default.
• W2055148524 hasConcept C203014093 @default.
• W2055148524 hasConcept C2778707650 @default.
• W2055148524 hasConcept C502942594 @default.
• W2055148524 hasConcept C542903549 @default.
• W2055148524 hasConcept C54355233 @default.
• W2055148524 hasConcept C55493867 @default.
• W2055148524 hasConcept C81885089 @default.
• W2055148524 hasConcept C86803240 @default.
• W2055148524 hasConcept C89423630 @default.
• W2055148524 hasConceptScore W2055148524C104317684 @default.
• W2055148524 hasConceptScore W2055148524C105580179 @default.
• W2055148524 hasConceptScore W2055148524C114851261 @default.
• W2055148524 hasConceptScore W2055148524C133936738 @default.
• W2055148524 hasConceptScore W2055148524C153911025 @default.
• W2055148524 hasConceptScore W2055148524C159654299 @default.
• W2055148524 hasConceptScore W2055148524C175656101 @default.
• W2055148524 hasConceptScore W2055148524C203014093 @default.
• W2055148524 hasConceptScore W2055148524C2778707650 @default.
• W2055148524 hasConceptScore W2055148524C502942594 @default.
• W2055148524 hasConceptScore W2055148524C542903549 @default.
• W2055148524 hasConceptScore W2055148524C54355233 @default.
• W2055148524 hasConceptScore W2055148524C55493867 @default.

• next